Market Tracker

10/21 2:23pm ET

Repligen Corp (NASDAQ:RGEN)

22.88
Data as of 2:08pm ET
 +0.125 / +0.55%
Today’s Change
9.97
Today|||52-Week Range
24.68
+67.71%
Year-to-Date

Today’s Trading

Previous close22.75
Today’s open22.87
Day’s range22.55 - 22.95
Volume132,154
Average volume (3 months)390,144
Market cap$742.7M
Dividend yield--
Data as of 2:08pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-46.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio45.8
Price/Sales6.34
Price/Book6.99

Competitors

 Today’s
change
Today’s
% change
ASPXAuspex Pharmaceutica...+0.08+0.30%
TTPHTetraphase Pharmaceu...+0.29+1.23%
RPTPRaptor Pharmaceutica...-0.11-1.02%
EBSEmergent BioSolution...-0.24-1.11%
Data as of 2:22pm ET, 10/21/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$0.04
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts